Organization
TESARO, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
TESARO, Inc.
... TerSera will be responsible for VARUBI in the U.S. and Canada, and TESARO will continue to commercialize VARUBY in Europe and will retain rest of ...
... WALTHAM, Mass., June 29, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology focused biopharmaceutical company, announced today that it has drawn ...
... TESARO to Receive $40 Million, plus Potential for Additional Milestone Payments and Royalties ...
... Inc., Novartis AG, Pfizer, Inc., Quest Diagnostics Inc., Roche Holding AG and Tesaro, Inc. Report Includes: - 28 data tables and 9 additional tables - ...
... (NYSE:DCT), Community Healthcare Trust Incorporated (NYSE:CHCT), Wabash National Corporation (NYSE:WNC), and Tesaro, Inc. (NASDAQ:TSRO), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst ...
... PARP inhibitor, talazoparib, but that drug was facing stiff competition from AstraZeneca, Tesaro, Clovis Oncology and others. Now things are finally looking up for Pfizer. ...
... ZUG, Switzerland - TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced the National Institute for ...
... pharma companies by 2017 revenue - AstraZeneca AstraZeneca already leads its PARP competitors—Tesaro's Zejula and Clovis' Rubraca—when it comes to FDA approvals, thanks to the ...
... WALTHAM, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that it has entered into ...
... in triple-negative breast cancer CHICAGO, June 04, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, summarized the results of the TOPACIO and ...
Subscribe now for full coverage on TESARO, Inc.
Start My Free Trial